| 2026-02-26 | Class II | Levothyroxine Sodium Tablets USP 150 mcg, 1000 Tablets bottle, Rx Only, Manufactured for: Macleods Pharma USA, | MACLEODS PHARMA USA, INC |
| 2025-12-31 | Class II | Levothyroxine Sodium Tablets, USP, Thyro-Tabs, 150mcg, 1000 Tablets, Rx only, Manufactured by: LLOYD, Inc., Sh | Alvogen, Inc |
| 2025-09-16 | Class II | Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 90 Tablets per bottle, Rx Only, Manufactured for Accord | ACCORD HEALTHCARE, INC. |
| 2025-07-29 | Class II | Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., N | Pfizer |
| 2025-06-20 | Class II | Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Hea | ACCORD HEALTHCARE, INC. |
| 2025-06-20 | Class II | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 1000-count bottle, Rx Only, Manufactured for: Accord He | ACCORD HEALTHCARE, INC. |
| 2025-06-20 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Hea | ACCORD HEALTHCARE, INC. |
| 2025-06-20 | Class II | Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 90-count bottle, Rx Only, Manufactured for: Accord Healt | ACCORD HEALTHCARE, INC. |
| 2025-06-20 | Class II | Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 1000-count bottle, Rx Only, Manufactured for: Accord He | ACCORD HEALTHCARE, INC. |
| 2025-06-20 | Class II | Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Heal | ACCORD HEALTHCARE, INC. |
| 2025-06-20 | Class II | Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 90-count bottle, Rx Only, Manufactured for: Accord Health | ACCORD HEALTHCARE, INC. |
| 2025-05-29 | Class III | Levothyroxine Sodium Tablets, USP 112 mcg (0.112mg), 1000 tablets, Rx Only, Manufactured for: Macleods Pharma | Macleods Pharmaceuticals Ltd |
| 2025-04-10 | Class II | Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcar | ACCORD HEALTHCARE, INC. |
| 2025-04-10 | Class II | Levothyroxine Sodium Tablets, USP, 50 mcg (0.05 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcare | ACCORD HEALTHCARE, INC. |
| 2025-04-10 | Class II | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 90 bottles, Rx Only, Manufactured for Accord Healthcare | ACCORD HEALTHCARE, INC. |
| 2025-04-10 | Class II | Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg), 1000 bottles, Rx Only, Manufactured for Accord Healthcar | ACCORD HEALTHCARE, INC. |
| 2025-03-07 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.15 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of | Mylan Institutional, Inc. |
| 2025-03-07 | Class II | Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), Rx Only, 100 Unit Dose Blister Cards of 10 (10 cards of | Mylan Institutional, Inc. |
| 2024-12-20 | Class II | Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmace | Lupin Pharmaceuticals Inc. |
| 2024-11-19 | Class II | Levothyroxine Sodium Tablets, USP, 100 mcg (0.1 mg), 100 Tablets per carton (10 unit dose blister cards of 10 | Mylan Institutional, Inc. |
| 2024-11-19 | Class II | Levothyroxine Sodium Tablets, USP, 137 mcg (0.137 mg), 100 Tablets per carton (10 unit dose blister cards of 1 | Mylan Institutional, Inc. |
| 2024-11-19 | Class II | Levothyroxine Sodium Tablets, USP, 112 mcg (0.112 mg), 100 Tablets per carton (10 unit dose blister cards of 1 | Mylan Institutional, Inc. |
| 2024-11-19 | Class II | Levothyroxine Sodium Tablets, USP, 150 mcg (0.150 mg), 100 Tablets per carton (10 unit dose blister cards of 1 | Mylan Institutional, Inc. |
| 2024-11-19 | Class II | Levothyroxine Sodium Tablets, USP, 125 mcg (0.125 mg), 100 Tablets per carton (10 unit dose blister cards of 1 | Mylan Institutional, Inc. |
| 2024-11-19 | Class II | Levothyroxine Sodium Tablets, USP, 175 mcg (0.175 mg), 100 Tablets per carton (10 unit dose blister cards of 1 | Mylan Institutional, Inc. |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0378-1805-77) and b) 1000-count | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC 0378-1817-77) and b) 1000-coun | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0378-1807-77) and b) 1000-count | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 150 mcg, packaged in a) 90-count bottles (NDC 0378-1815-77) and b) 1000-coun | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0378-1803-77) and b) 1000-count | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 200 mcg, packaged in a) 90-count bottles (NDC 0378-1819-77) and b) 1000-coun | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0378-1800-77) and b) 1000-count | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC 0378-1823-77) and b) 1000-coun | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC 0378-1811-77) and b) 1000-coun | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 125 mcg, packaged in a) 90-count bottles (NDC 0378-1813-77) and b) 1000-coun | Viatris Inc |
| 2024-11-18 | Class II | Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC 0378-1809-77) and b) 1000-coun | Viatris Inc |
| 2024-11-08 | Class II | Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg), 1000-count bottle, Rx Only, Manufactured for: Accord Hea | ACCORD HEALTHCARE, INC. |
| 2023-10-17 | Class III | Synthroid, Levothyroxine Sodium Tablets, USP 125mcg (0.125mg), 100-count bottle, Rx Only AbbVie Inc. North Chi | AbbVie Inc. |
| 2023-02-06 | Class II | Levothyroxine Sodium Tablets, USP 112 mcg, 90 tablets per bottle, Rx Only, Manufactured by Lloyd Inc., Shenand | Alvogen, Inc |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 125 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufa | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 88 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufact | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 25 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufact | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 200 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufac | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 37.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufa | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 150 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufac | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 75 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufact | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 44 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufac | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 50 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufact | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 13 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufact | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 175 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufa | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 100 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufac | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 137 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufac | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 62.5 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufa | IBSA PHARMA INC |
| 2023-01-30 | Class II | TIROSINT - SOL (levothyroxine sodium) Oral Solution, 112 microgram/mL; 6 pouches x 5 ampules, Rx Only; Manufac | IBSA PHARMA INC |
| 2021-03-15 | Class II | LEVOXYL Tablets, USD, 150MCG, 100-count bottle, Rx Only, Distributed by Pfizer Inc., New York, NY 10017, MADE | Cardinal Health Inc. |
| 2021-03-15 | Class II | TIROSINT(levothyroxine sodium) capsules 175MCG 3 blisters X10 capsules; NDC/UPC 71858-0055-4; RX; CAPSULES | Cardinal Health Inc. |
| 2021-03-15 | Class II | Levothyroxine Sodium Tablets, USP 125 mcg (0.125 mg) 90 Tablets Rx only NDC 0378-1813-77 Mylan Pharmaceuticals | Cardinal Health Inc. |
| 2018-12-06 | Class II | Levoxyl (levothyroxine sodium tablets, USP) tablets 112 mcg, 100-count bottle, Rx Only,Distributed by Pfizer | Pfizer Inc. |
| 2016-11-07 | Class II | LEVOXYL(R) (levothyroxine sodium tablets, USP), 200 mcg, 100 count bottles, Rx only, Manufactured and Distribu | Pfizer Inc. |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-04-30 | Class II | Levoxyl (levothyroxine sodium) tablets, USP, 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and | King Legacy, a wholly owned subsidiary of Pfizer |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 200 mcg, packaged in a) 100-count bottles (NDC 60793-860-01) and b | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 88 mcg, packaged in a) 100-count bottles (NDC 60793-853-01) and b) | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 137 mcg, packaged in a) 100-count bottles (NDC 60793-857-01) and b | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 112 mcg, packaged in a) 100-count bottles (NDC 60793-855-01) and b | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 175 mcg, packaged in a) 100-count bottles (NDC 60793-859-01) and b | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 25 mcg, packaged in a) 100-count bottles (NDC 60793-850-01) and b) | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 75 mcg, packaged in a) 100-count bottles (NDC 60793-852-01) and b | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 150 mcg, packaged in a) 100-count bottles (NDC 60793-858-01) and b | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 125 mcg, packaged in a) 100-count bottles (NDC 60793-856-01) and | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 50 mcg, packaged in a) 100-count bottles (NDC 60793-851-01) and b) | Pfizer Inc. |
| 2013-03-28 | Class II | Levoxyl (levothyroxine sodium) tablets, USP 100 mcg, packaged in a) 100-count bottles (NDC 60793-854-01) and b | Pfizer Inc. |
| 2012-12-04 | Class II | Synthroid (Levothyroxine Sodium) tablets, 150 mcg (0.15 mg), 90 tablets per bottle, Rx Only, NDC 0074-7069-90; | Abbott Laboratories |
| 2012-07-19 | Class II | Synthroid (levothyroxine sodium) Tablets USP, 50 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chi | Abbott Laboratories |
| 2012-07-19 | Class II | Synthroid (levothyroxine sodium) Tablets USP, 75 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Chi | Abbott Laboratories |
| 2012-07-19 | Class II | Synthroid (levothyroxine sodium) Tablets USP, 112 mcg, Rx Only, 90-Count Bottle, Abbott Laboratories, North Ch | Abbott Laboratories |